Mayo Clinic has made important contributions to research on PSC including determining its cause, improving treatment and assessing the results of liver transplants. Mayo continues to be involved in research for PSC, including clinical trials to halt disease progression. Mayo has developed mathematical models to help physicians predict long-term survival for patients with this disease.
See a list of publications by Mayo Clinic doctors on primary sclerosing cholangitis on PubMed, a service of the National Library of Medicine.
Research descriptions of individual investigators: